Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-
alcoholic fatty liver disease, has a high global prevalence and can progress to metabolic …

Background Metabolic dysfunction associated steatotic liver disease (MASLD), closely
linked to excessive lipogenesis, induces chronic liver disease. MASLD often cause other …

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-
alcoholic fatty liver disease (NAFLD), is characterized by intrahepatic triglyceride …

Macrophages are essential for the proper inflammatory and reparative processes that lead
to regeneration of skeletal muscle after injury. Recent studies have demonstrated close links …

Background Metabolic-associated fatty liver disease (MAFLD) is the leading chronic liver
disease globally, impacting a large segment of the population. The Zhuyu Pill (ZYP), a …

In recent years, there has been increasing interest in exploring the potential therapeutic
advantages of Citrullus mucosospermus extracts (CME) for nonalcoholic steatohepatitis …

Non-alcoholic fatty liver disease (NAFLD) is the leading chronic liver disease worldwide,
with a progressive form of non-alcoholic steatohepatitis (NASH). It may progress to …

Cholesterol and its metabolites play a crucial role in cancer development and suppression
of immune responses. In recent years, a large number of experimental and clinical studies …

Nonalcoholic fatty liver disease (NAFLD) has become the most common liver disease in the
world and is an important risk factor for the progression to hepatocellular carcinoma …